Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ayesha A Shafi

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Clocks & Sleep|March 27, 2024
Temporal Considerations in Brain Metastases Radiation Therapy: The Intersection of Chronobiology and Patient ProfilesNicolas G Nelson, Sara E Burke, Louis Cappelli, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
PARP inhibition and pharmacological ascorbate demonstrate synergy in castration-resistant prostate cancerNicolas Gordon, Peter T Gallagher, Neermala Poudel Neupane, et al.
Molecular Oncology|January 14, 2026
PARP inhibition and pharmacological ascorbate demonstrate synergy in castration-resistant prostate cancerNicolas Gordon, Peter T Gallagher, Orly I Richter, et al.
Cancer Research|October 9, 2021
Novel Oncogenic Transcription Factor Cooperation in RB-Deficient CancerAmy C Mandigo, Ayesha A Shafi, Jennifer J McCann, et al.
Cancer Research|November 20, 2019
USP22 Functions as an Oncogenic Driver in Prostate Cancer by Regulating Cell Proliferation and DNA RepairJennifer J McCann, Irina A Vasilevskaya, Neermala Poudel Neupane, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Stage-Specific Regulation of DNA Damage Repair by the Circadian Regulator, CRY1, in Prostate CancerArwa Fallatah, Stefan DiFazio, Lakshmi Ravindranath, et al.
European Urology Oncology|November 24, 2018
Patient-derived Models Reveal Impact of the Tumor Microenvironment on Therapeutic ResponseAyesha A Shafi, Matthew J Schiewer, Renée de Leeuw, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancerSumaira Sardar, Christopher M McNair, Lakshmi Ravindranath, et al.
Nature Communications|January 16, 2021
The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repairAyesha A Shafi, Chris M McNair, Jennifer J McCann, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
EZH2-TTP-mTORC1 Axis Drives Phenotypic Plasticity and Therapeutic Vulnerability in Lethal Prostate CancerBeatriz German, Katherine L Morel, Teia Noel, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Clocks & Sleep|March 27, 2024
Temporal Considerations in Brain Metastases Radiation Therapy: The Intersection of Chronobiology and Patient ProfilesNicolas G Nelson, Sara E Burke, Louis Cappelli, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
PARP inhibition and pharmacological ascorbate demonstrate synergy in castration-resistant prostate cancerNicolas Gordon, Peter T Gallagher, Neermala Poudel Neupane, et al.
Molecular Oncology|January 14, 2026
PARP inhibition and pharmacological ascorbate demonstrate synergy in castration-resistant prostate cancerNicolas Gordon, Peter T Gallagher, Orly I Richter, et al.
Cancer Research|October 9, 2021
Novel Oncogenic Transcription Factor Cooperation in RB-Deficient CancerAmy C Mandigo, Ayesha A Shafi, Jennifer J McCann, et al.
Cancer Research|November 20, 2019
USP22 Functions as an Oncogenic Driver in Prostate Cancer by Regulating Cell Proliferation and DNA RepairJennifer J McCann, Irina A Vasilevskaya, Neermala Poudel Neupane, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Stage-Specific Regulation of DNA Damage Repair by the Circadian Regulator, CRY1, in Prostate CancerArwa Fallatah, Stefan DiFazio, Lakshmi Ravindranath, et al.
European Urology Oncology|November 24, 2018
Patient-derived Models Reveal Impact of the Tumor Microenvironment on Therapeutic ResponseAyesha A Shafi, Matthew J Schiewer, Renée de Leeuw, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancerSumaira Sardar, Christopher M McNair, Lakshmi Ravindranath, et al.
Nature Communications|January 16, 2021
The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repairAyesha A Shafi, Chris M McNair, Jennifer J McCann, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
EZH2-TTP-mTORC1 Axis Drives Phenotypic Plasticity and Therapeutic Vulnerability in Lethal Prostate CancerBeatriz German, Katherine L Morel, Teia Noel, et al.
Pageof 3